EuroBiotech: More articles of note


> ImCheck Therapeutics named René Hoet, Ph.D., as CSO. Hoet joins the French biotech from Bayer, where he was responsible for antibody lead discovery. Statement

> Shares in Foamix jumped after it posted top-line data from a phase 3 trial of FMX101 in moderate-to-severe acne. Release 

> ProQR Therapeutics raised $104 million in an underwritten public offering. Statement 


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

> Valbiotis posted data from a phase 1/2 obesity trial. The company plans to advance the candidate into a larger study. Release 

> Glythera rebranded as Iksuda Therapeutics as part of a shift from technology licensing to cancer drug development. Statement 

> Innate Pharma enrolled the first patient in its IPH5401-Imfinzi combination trial. Release